Skip to main content

Table 3 Characteristics of individual patients with hypoglycemia

From: Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring

  Sex/age BMI (kg/m2) DM duration (years) Blood glucose level (mg/dL) HbA1c (%) HOMA-IR Urinary CPR (μg/day) Therapy
1 M/72 23.8 1 64 6.4 DPP4i
2 F/75 20.8 25 63 6.4 0.7 12.9 Insulin mix50
3 M/58 21.2 38 56 6.8 Insulin, DPP4i
4 F/73 25.2 25 42 6.9 11.1 Insulin mix30
5 F/17 21.0 5 65 7.3 0.8 29.3 Biguanides
6 F/57 30.9 5 60 7.4 1.1 75.6 DPP4i
7 M/74 23.7 17 64 7.6 1.1 Insulin mix25
8 M/70 27.4 32 62 7.6 0.7 19.4 Sulfonylureas, DPP4i, biguanides, Thiazolidinedione
9 F/79 15.9 13 67 8 11.6 Insulin, αGI
10 F/67 22.0 9 65 8.1 5.9 41.7 DPP4i, glinide, αGI
11 M/34 27.3 4 57 8.4 0.9 14.4 DPP4i
12 M/70 34.0 11 65 8.5 9.6 104.8 DPP4i
13 F/70 22.4 25 47 8.5 0.9 32 Sulfonylureas, DPP4i, Thiazolidinedione
14 M/36 38.4 2 59 8.6 9.0 182.1 DPP4i
15 F/65 20.6 30 60 8.7 1.8 24.9 Sulfonylureas, DPP4i, biguanides
  1. See Table 1 for abbreviations